Document Detail


Implications for a reduced DNA-elongation rate in polyamine-depleted cells.
MedLine Citation:
PMID:  2115438     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatment of Ehrlich ascites tumor cells with 2-difluoromethylornithine (F2MeOrn), an enzyme-activated irreversible inhibitor of ornithine decarboxylase, resulted in depleted putrescine and spermidine content, and reduced growth rate. We have previously shown that adenine ribonucleotide levels are substantially increased in these polyamine-depleted cells. The present paper addresses the question whether the elevated ATP pool is accompanied by a concomitant increase in the dATP pool. If this is the case, the observed growth inhibition could be explained by the well-known dATP-mediated feedback inhibition of ribonucleotide reductase. We found that dNTP pools were not unbalanced and that dNTP synthesis was not arrested in polyamine-depleted cells. Moreover, the dNTP content and the activity of ribonucleotide reductase (CDP reduction) and thymidylate synthase, remained elevated despite the fact that the cells were inhibited in their growth by F2MeOrn treatment. Incorporation of a radiolabeled precursor into DNA was initially lower in F2MeOrn-treated. cells than in control cells. However, while incorporation of a radiolabeled precursor into DNA decreased markedly in plateau-phase control cells, it remained at a higher level in cells inhibited in growth by polyamine depletion. This discrepancy may be explained by the fact that polyamine-depleted cells accumulated in the S phase, and that they had an increased content of acid-soluble radiolabeled DNA precursor. Our data indicate that polyamine depletion adversely affects the DNA synthetic machinery by reducing the rate of elongation.
Authors:
S M Oredsson; B Nicander; O Heby
Related Documents :
3102048 - Synergistic inhibition of polyamine synthesis and growth by difluoromethylornithine plu...
6433658 - Polyamine biosynthetic enzymes as targets in cancer chemotherapy.
14025178 - Chromosomal and nucleolar rna synthesis in root tips during mitosis.
6950168 - Basis for the differential action of aminonucleoside on normal and transformed human fi...
7521858 - Neuritogenic lewis rat t cells use tcrb chains that include a new tcrb-v8 family member.
2014548 - Renal allograft rejection. functional impairment of kidney epithelial cell monolayers m...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of biochemistry / FEBS     Volume:  190     ISSN:  0014-2956     ISO Abbreviation:  Eur. J. Biochem.     Publication Date:  1990 Jul 
Date Detail:
Created Date:  1990-08-24     Completed Date:  1990-08-24     Revised Date:  2007-07-23    
Medline Journal Info:
Nlm Unique ID:  0107600     Medline TA:  Eur J Biochem     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  483-9     Citation Subset:  IM    
Affiliation:
Department of Zoo Physiology, University of Lund, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Carcinoma, Ehrlich Tumor / metabolism*
Cell Cycle / drug effects
Cell Division / drug effects
DNA Replication / drug effects
DNA, Neoplasm / biosynthesis*,  drug effects
Deoxyribonucleotides / metabolism*
Eflornithine / pharmacology*
Kinetics
Mice
Putrescine / metabolism*
Spermidine / metabolism*
Thymidylate Synthase / metabolism*
Tumor Cells, Cultured / cytology,  drug effects,  metabolism
Chemical
Reg. No./Substance:
0/DNA, Neoplasm; 0/Deoxyribonucleotides; 110-60-1/Putrescine; 124-20-9/Spermidine; 70052-12-9/Eflornithine; EC 2.1.1.45/Thymidylate Synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Consistency of seizure frequency estimates across time, methods, and observers.
Next Document:  Purification and characterization of a DNA polymerase from the archaebacterium Thermoplasma acidophi...